BIOCYTOGEN-B (02315) issued 47.5 million A-shares on December 10th.
Baoshitu-B (02315) announced that 47.5 million A shares will be issued on December 10, 2025; 2.886 billion non-listed shares will be converted into 2.886 billion A shares.
BIOCYTOGEN-B (02315) announced the issuance of 47.5 million A shares on December 10, 2025; and the conversion of 288.6 million unlisted shares into 288.6 million A shares.
Related Articles
Lens Technology (06613) is planning to acquire 100% of the equity of Pei Mei Gao International.
Citibank: Three major factors driving the growth of luxury consumption in Hong Kong, optimistic about high-end consumer rental stocks.
Intel Corporation (INTC.US) is nearing a deal to acquire SambaNova Systems, with the transaction amount potentially being less than $5 billion.
Lens Technology (06613) is planning to acquire 100% of the equity of Pei Mei Gao International.
Citibank: Three major factors driving the growth of luxury consumption in Hong Kong, optimistic about high-end consumer rental stocks.
Intel Corporation (INTC.US) is nearing a deal to acquire SambaNova Systems, with the transaction amount potentially being less than $5 billion.
RECOMMEND
McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
